Back to the main directory
EarningsReview / Equity
- Genmab (Buy, TP: DKK2900.00) - Low end of 2022 guidance raised by DnB Markets
- Carasent (Buy, TP: NOK45.00) - Still on course for strong growth by DnB Markets
- SFL Corporation Ltd (Hold, TP: USD10.00) - Good earnings visibility by DnB Markets
- DHT Holdings (Hold, TP: USD5.70) - NAV support but soft markets by DnB Markets
- Mowi (Hold, TP: NOK270.00) - In line with expectations by DnB Markets
- Sparebanken Øst (Hold, TP: NOK58.00) - Cautious growth strategy by DnB Markets
- NRC Group (Buy, TP: NOK35.00) - On track by DnB Markets
- Norway Royal Salmon (Buy, TP: NOK265.00) - Profit warning for Q1 by DnB Markets
- Canadian General Investments - Keeping the faith during stock market volatility by Edison Investment Research
- Ocean Wilsons Holdings - FY21 was in line but headwinds remain by Edison Investment Research
- Technicolor - Division on schedule by Edison Investment Research
- Poland Food Retail by HSBC
- Itaú BBA on Banrisul: In-Line 1Q22 – Good Credit Quality but Softer NIMs by Itau
- Itaú BBA on Modalmais: A Softer Quarter, as Expected by Itau
- Itaú BBA on Healthcare & Education: 1Q22 Earnings – VSTA, COGN, PARD, RDOR and YDUQ by Itau
- Itaú BBA on B3: 1Q22 Results – Expenses Running High by Itau
- Solid delivery amidst the turbulence by BNP Paribas Exane
- Hope and fear by BNP Paribas Exane
- Scrap and energy tailwinds aid margin performance by BNP Paribas Exane
- Risks increasingly priced in by BNP Paribas Exane
- CMD unlocks potential, but investors underwhelmed by BNP Paribas Exane
- ACS: RDOS. 1T’22 Y CAMBIO DE P.O. A LA BAJA (ANÁLISIS BANCO SABADELL) by Sabadell
- TALGO: RDOS. 1T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Investment Daily 13/05/2022 by BNP Paribas Exane
- Updating post Q1 by BNP Paribas Exane